Panel Discussion: Contrasting Bispecific Therapeutics & CAR-T Approaches
Time: 9:25 am
• Evaluate off-the-shelf verses personalized therapies
• Understand how contrasting bispecific approaches manage safety for on target off tumor toxicities
• Investigate differences in solid and liquid tumour targeting
• Examine whether discussed therapeutics are to be considered cures or therapies bridging the gap for the next breakthrough?